By [Your Name/Editorial Staff]
June 01, 2026
For decades, the conversation surrounding BRCA mutations—specifically BRCA1 and BRCA2—has been almost exclusively framed through the lens of women’s health. The association with breast and ovarian cancer is deeply ingrained in the public consciousness, often leaving men to believe that genetic testing is a concern for their wives, sisters, or daughters, but not for themselves.
However, as personal stories and clinical data continue to emerge, that narrative is shifting. The reality is that BRCA mutations do not discriminate by gender. Men who carry these mutations are not only at an increased risk for specific cancers themselves, but they also serve as a vital link in the hereditary chain. When men are left out of the conversation, entire families miss the opportunity for early detection and life-saving intervention.
The Personal Catalyst: A Journey from Patient to Advocate
Doug Bank, a long-time cancer advocate and member of the Sharsheret Men’s Leadership Council, knows this reality intimately. His journey began not with a genetic test, but with a Stage I testicular cancer diagnosis at age 26. While not typically linked to BRCA, the experience of navigating an aggressive treatment plan—one he later realized was more invasive than necessary—ignited a fire for patient advocacy.
“Trying to sort that out for myself eventually led me to look for better information, more opinions, and a clearer understanding of the choices I actually had,” Bank reflects. This personal struggle evolved into a career dedicated to improving cancer care for adolescents and young adults, eventually leading him to the LIVESTRONG Young Adult Alliance. It was there he first crossed paths with Rochelle Shoretz, the visionary founder of Sharsheret, an organization dedicated to supporting women and families facing breast and ovarian cancer.
Years later, the abstract concept of genetic risk became a concrete family crisis. Following a routine inquiry from his wife’s doctor regarding family history, Bank began to piece together a pedigree that was impossible to ignore. His father had battled prostate cancer, his aunt had been diagnosed with breast cancer, and his grandmother had passed away from the disease before he was even born. Further investigation revealed a devastating pattern: nearly every female cousin on his father’s side had been diagnosed with breast or ovarian cancer. In 2009, Bank tested positive for a BRCA2 mutation.
The Chronology of Awareness: A Generational Impact
The timeline of Bank’s discovery illustrates the often-delayed process of genetic awareness in families:
- 1990s–Early 2000s: Bank is diagnosed with testicular cancer and begins his advocacy work, focusing on young adult survivorship.
- 2009: Following the recommendation of his wife’s physician and a review of his own family’s cancer history, Bank undergoes genetic testing and receives a positive result for the BRCA2 mutation.
- The Post-Diagnosis Years: Bank’s brother is diagnosed with pancreatic cancer—a malignancy strongly associated with BRCA2. Despite the severity, the genetic knowledge allowed for more targeted, albeit challenging, care.
- The Second Generation: Recognizing the hereditary nature of the mutation, Bank and his wife elect to test their children. Two of his children test positive for the BRCA2 mutation.
- 2026: Now 56, Bank is diagnosed with prostate cancer, another malignancy linked to his genetic profile. Having the knowledge of his status allowed for earlier, more informed decision-making than he had experienced in his youth.
Supporting Data: Why BRCA Matters for Men
The clinical implications for men carrying BRCA mutations are significant and often under-discussed. While women with BRCA mutations face heightened risks for breast and ovarian cancer, men with these same mutations face an elevated risk for:
- Prostate Cancer: Men with a BRCA2 mutation have a significantly higher risk of developing prostate cancer, which often presents at a younger age and can be more aggressive than in the general population.
- Male Breast Cancer: While rare, men with BRCA mutations have a higher risk of developing breast cancer than the general male population, necessitating awareness of physical changes.
- Pancreatic Cancer: BRCA2 mutations are a known risk factor for pancreatic cancer, a disease where early detection is notoriously difficult and critical.
- Melanoma: Some studies suggest a potential link between BRCA mutations and an increased risk of specific skin cancers.
According to the National Cancer Institute, while the general population risk for prostate cancer is significant, carriers of the BRCA2 mutation face a risk that is three to seven times higher than the average. Despite these statistics, many men remain unaware of their risk status, largely due to the pervasive "women’s health" framing of the gene.
Official Responses and Medical Perspectives
Medical experts and genetic counselors increasingly emphasize that a "pedigree" approach—mapping out cancer across both maternal and paternal lines—is the first line of defense.
"Genetic information can create anxiety," Bank notes. "I understand that. But not knowing does not make the risk go away. It only leaves families with fewer chances to act."
The debate over testing children, which Bank’s family navigated, remains a nuanced topic in the medical community. While some practitioners express concerns regarding the psychological burden on minors, advocates argue that the anxiety of not knowing—when a parent is known to carry a mutation—is often more debilitating. For Bank’s daughter, having this information was transformative. When she discovered a lump at age 24, she was able to navigate the healthcare system with urgency, bypassing the "you’re too young for cancer" dismissal that often delays diagnosis in younger patients.
Implications for Future Care and Family Health
The implications of this movement are twofold: clinical and social.
Clinical Implications
Health systems must transition toward gender-neutral genetic screening protocols. When a patient presents with a strong family history of cancer, the assessment should automatically trigger an inquiry into the patient’s male relatives. Furthermore, clinical trials and oncology guidelines should explicitly include BRCA-positive men in surveillance programs for prostate and pancreatic cancers.
Social Implications
Organizations like Sharsheret have evolved to recognize that cancer is a "family affair." By inviting men onto leadership councils and into support networks, these organizations are validating the experience of male caregivers and male patients alike. The goal is to strip away the stigma of genetic testing, reframing it not as a "women’s issue" but as a foundational pillar of family health management.
Conclusion: Knowledge as a Protective Shield
The story of the Bank family serves as a poignant reminder that genetic knowledge is a tool of empowerment, not just a precursor to anxiety. While the diagnosis of cancer is never a welcome event, the ability to anticipate risk and implement proactive surveillance can be the difference between a treatable condition and a terminal one.
As Doug Bank emphasizes, "Men should not stand outside these conversations." Whether it is through initiating the genetic testing process, documenting the family pedigree, or supporting a spouse or child through their own diagnostic journey, men play a central role in the fight against hereditary cancer.
The path forward requires a systemic shift in how we communicate genetic risk. It requires an acknowledgment that every family tree has roots that run through both mothers and fathers. By normalizing the participation of men in the BRCA conversation, we can move closer to a future where families are no longer blindsided by preventable or treatable malignancies, but are instead equipped with the knowledge needed to secure their future.
About the Author
